Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Medtronic
Teva
Express Scripts
Colorcon
Healthtrust
McKesson
Deloitte
McKinsey

Generated: June 24, 2018

DrugPatentWatch Database Preview

MEXITIL Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Mexitil, and what generic alternatives are available?

Mexitil is a drug marketed by Boehringer Ingelheim and is included in one NDA.

The generic ingredient in MEXITIL is mexiletine hydrochloride. There are five drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the mexiletine hydrochloride profile page.
Summary for MEXITIL
Drug patent expirations by year for MEXITIL
Medical Subject Heading (MeSH) Categories for MEXITIL
Synonyms for MEXITIL
(+-)-1-(2,6-dimethylphenoxy)propan-2-amine
(+-)-1-Methyl-2-(2,6-xylyloxy)ethylamine hydrochloride
(+)-(S)-Mexiletine Hydrochloride
(+)-Mexiletine Hydrochloride
(+/-)-Mexiletine
(2RS)-1-(2,6-dimethylphenoxy)-2-aminopropane
(2S)-1-(2,6-Dimethylphenoxy)-2-propanamine Hydrochloride
(RS)-Mexiletine
1-(2,6-Dimethylphenoxy)-2-amino propane
1-(2,6-dimethylphenoxy)-2-amino-propane hydrochloride
1-(2,6-dimethylphenoxy)-2-amino-propane hydrochloride;
1-(2,6-Dimethylphenoxy)-2-aminopropane
1-(2,6-Dimethylphenoxy)-2-aminopropane hydrochloride
1-(2,6-Dimethylphenoxy)-2-propanamine
1-(2,6-Dimethylphenoxy)-2-propanamine hydrochloride
1-(2,6-Dimethylphenoxy)-2-propanamine hydrochloride, 97%
1-(2,6-dimethylphenoxy)-2-propananmineHydrochloride
1-(2,6-dimethylphenoxy)-2-propanolamine
1-(2,6-Dimethylphenoxy)-2-propylamine Hydrochloride
1-(2,6-dimethylphenoxy)prop-2-ylamine
1-(2,6-dimethylphenoxy)prop-2-ylamine, chloride
1-(2,6-dimethylphenoxy)propan-2-amine
1-(2,6-dimethylphenoxy)propan-2-amine hydrochloride
1-(2,6-dimethylphenoxy)propan-2-amine;hydrochloride
1-(2,6-dimethylphenoxy)propan-2-aminhydrochlorid
1-(2,6-dimethylphenoxy)propan-2-aminium chloride
1-(2,6-Xylyloxy)-2-aminopropane
1-(2,6-Xylyloxy)-2-aminopropane hydrochloride
1-(2',6'-dimethyl-phenoxy)-2-amino-propane
1-(2',6'-Dimethylphenoxy)-2-aminopropane
1-METHYL-2-(2 6-XYLYLOXY)ETHYLAMMONIUM CHLORIDE
1-methyl-2-(2,6-xylyloxy)ethanamine
1-Methyl-2-(2,6-xylyloxy)ethylamine
1-Methyl-2-(2,6-xylyloxy)ethylamine Hydrochloride
1-Methyl-2-(2,6-xylyloxy)ethylamine hydrochloride
1-Methyl-2-(2,6-xylyloxy)ethylammonium chloride
180966-61-4
2-(2-Aminopropoxy)-1,3-DiMethyl-Benzene Hydrochloride
2-(2-aminopropoxy)-1,3-dimethylbenzene
2-(2-aminopropoxy)-1,3-dimethylbenzene hydrochloride
2-(2-azaniumylpropoxy)-1,3-dimethylbenzene chloride
2-(2,6-Dimethyl-phenoxy)-1-methyl-ethylamine
2-(2,6-Dimethyl-phenoxy)-1-methyl-ethylamine(Mexiletine)
2-(2,6-dimethylphenoxy)-1-methyl-ethylamine
2-(2,6-dimethylphenoxy)-1-methylethylamine
2-Amino-1-(2,6-dimethylphenoxy)propane
2-Propanamine, 1-(2,6-dimethylphenoxy)-
2-Propanamine, 1-(2,6-dimethylphenoxy)-, hydrochloride
2-Propanamine, 1-(2,6-dimethylphenoxy)-, hydrochloride, (+-)-
2-Propanamine,1-(2,4-dimethylphenoxy)-
31828-71-4
31828-71-4 (Parent)
370M014
5370-01-4
5370-01-4 (hydrochloride)
59890P
819066-98-3
828M714
AB00053683
AB00053683_10
AB00053683_11
AC-4260
AC-8240
AC1L1HL7
AC1L2IE1
AC1Q1RX7
AC1Q2BC5
AC1Q2BC6
AC1Q3993
AC1Q3DIN
AK-65058
AK163494
AKOS009139802
AKOS015890265
AN-12179
AN-8177
ANW-41640
AS-13790
BC205702
BC681107
BDBM50117271
BPBio1_000026
BRD-A64092382-003-04-3
BRN 2092205
BSPBio_000022
BSPBio_002254
C07220
CAS-5370-01-4
CCG-204869
CCG-213246
CHEBI:6916
CHEBI:6917
CHEMBL1200606
CHEMBL558
CPD000326711
CTK4D7767
CTK6A8839
D00639
D08215
D0X0RI
DB00379
DivK1c_000834
dl-mexiletine
DSSTox_CID_25783
DSSTox_GSID_45783
DSSTox_RID_81125
DTXSID2045783
DTXSID8048446
EBD30089
EINECS 226-362-1
EINECS 250-825-7
EN300-53944
EN300-54300
ETHYLAMINE, 1-METHYL-2-(2,6-XYLYLOXY)-
Ethylamine, 1-methyl-2-(2,6-xylyloxy)-, hydrochloride
EU-0100784
FT-0082653
FT-0605484
FT-0658952
GTPL2629
HMS1568B04
HY-A0093
I01-3629
I01-6374
IDI1_000834
J10321
Katen
KB-55046
KBio1_000834
KBio2_002082
KBio2_004650
KBio2_007218
KBio3_001474
KBioGR_001270
KBioSS_002082
KO 1173
Ko 1173 Cl
Ko 1173Cl
KO-1173
KO-1173 CL
KO-1173-Cl
KO1173
KOE-1173
KS-00000F9V
Lopac0_000784
LP00784
LS-68257
LS-68258
M 2727
M-2016
M2040
MCULE-1930292316
MCULE-4507699259
Mexiletene
Mexiletene hydrochloride
mexiletin HCl
mexiletin hydrochloride
Mexiletina
Mexiletina [INN-Spanish]
Mexiletine
Mexiletine (hydrochloride)
Mexiletine (INN)
Mexiletine [INN:BAN]
Mexiletine HCL
Mexiletine hydrochloride
Mexiletine hydrochloride (JP17/USP)
Mexiletine hydrochloride (Salt/Mix)
Mexiletine hydrochloride [USAN:JAN]
Mexiletine hydrochloride [USAN:USP:JAN]
Mexiletine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Mexiletine hydrochloride, powder
Mexiletine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Mexiletinehydrochloride
Mexiletinum
Mexiletinum [INN-Latin]
mexilitene
MEXILITENE HYDROCHLORIDE
Mexilitine
Mexitil (Salt/Mix)
Mexitil (TN)
Mexityl
MFCD00216024
MLS001056756
MLS002222239
MLS002548872
MolPort-001-790-944
MolPort-003-666-510
NC00682
NCGC00015659-02
NCGC00015659-03
NCGC00015659-04
NCGC00015659-05
NCGC00015659-06
NCGC00015659-07
NCGC00015659-08
NCGC00015659-09
NCGC00015659-10
NCGC00015659-11
NCGC00015659-14
NCGC00094121-01
NCGC00094121-02
NCGC00094121-03
NCGC00094121-04
NCGC00162253-01
NCGC00162253-02
NCGC00261469-01
NE17727
NFEIBWMZVIVJLQ-UHFFFAOYSA-N
NINDS_000834
NSC-758639
NSC758639
O654
OR004936
OR045397
OR053139
OR344776
Pharmakon1600-01503929
Prestwick_666
Prestwick0_000241
Prestwick1_000241
Prestwick2_000241
Prestwick3_000241
Ritalmex
s4225
SAM002264606
SBB003392
SBB070242
SBI-0050762.P003
SC-17488
SC-50523
SCHEMBL16081
SCHEMBL42226
SMR000326711
SPBio_002241
Spectrum_001602
SPECTRUM1503929
Spectrum3_000727
Spectrum4_000795
Spectrum5_001279
SR-01000075986
SR-01000075986-1
ST083488
ST24048103
TL8000021
Tox21_111249
Tox21_111249_1
Tox21_111249_2
Tox21_500784
TR-019000
V0364
VA11290
VLPIATFUUWWMKC-UHFFFAOYSA-N
W-105713
W-106874
Z818727398

US Patents and Regulatory Information for MEXITIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Boehringer Ingelheim MEXITIL mexiletine hydrochloride CAPSULE;ORAL 018873-002 Dec 30, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Boehringer Ingelheim MEXITIL mexiletine hydrochloride CAPSULE;ORAL 018873-003 Dec 30, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Boehringer Ingelheim MEXITIL mexiletine hydrochloride CAPSULE;ORAL 018873-004 Dec 30, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for MEXITIL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer Ingelheim MEXITIL mexiletine hydrochloride CAPSULE;ORAL 018873-003 Dec 30, 1985 ➤ Try a Free Trial ➤ Try a Free Trial
Boehringer Ingelheim MEXITIL mexiletine hydrochloride CAPSULE;ORAL 018873-004 Dec 30, 1985 ➤ Try a Free Trial ➤ Try a Free Trial
Boehringer Ingelheim MEXITIL mexiletine hydrochloride CAPSULE;ORAL 018873-002 Dec 30, 1985 ➤ Try a Free Trial ➤ Try a Free Trial
Boehringer Ingelheim MEXITIL mexiletine hydrochloride CAPSULE;ORAL 018873-004 Dec 30, 1985 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
US Department of Justice
Baxter
McKinsey
Federal Trade Commission
Moodys
Chinese Patent Office
Citi
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.